Shanghai Labway Clinical Laboratory Co., Ltd (SHE:301060)

China flag China · Delayed Price · Currency is CNY
10.71
+0.20 (1.90%)
Mar 10, 2026, 1:15 PM CST
-2.72%
Market Cap 4.19B
Revenue (ttm) 1.52B
Net Income (ttm) -69.52M
Shares Out 398.52M
EPS (ttm) -0.17
PE Ratio n/a
Forward PE n/a
Dividend 0.20 (1.89%)
Ex-Dividend Date n/a
Volume 4,563,200
Average Volume 6,302,278
Open 10.29
Previous Close 10.51
Day's Range 10.29 - 10.73
52-Week Range 7.66 - 14.55
Beta 0.57
RSI 41.79
Earnings Date Apr 29, 2026

About SHE:301060

Shanghai Labway Clinical Laboratory Co., Ltd. engages in the sale of in-vitro diagnostic products in China. The company distributes in-vitro diagnostic instruments, reagents, and related accessories and consumables. It also provides third-party medical testing, pathological diagnosis services, precision medicine, CRO, and sample bank laboratory services; scientific research technology and testing; and professional technical support services. In addition, the company offers rental, business, and human resources services. Further, it operates Lan... [Read more]

Sector Healthcare
Founded 1993
Employees 1,365
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 301060
Full Company Profile

Financial Performance

In 2024, SHE:301060's revenue was 1.74 billion, an increase of 4.05% compared to the previous year's 1.67 billion. Losses were -109.44 million, -22.71% less than in 2023.

Financial Statements

News

There is no news available yet.